Cohen et al. (2026) “mRNA delivery of mosaic-8 pan-sarbecovirus RBD vaccines elicits distinct antibody epitope signatures” Cell Reports.
DOI: 10.1016/j.celrep.2026.117335
Read
about Cohen et al. (2026) “mRNA delivery of mosaic-8 pan-sarbecovirus RBD vaccines elicits distinct antibody epitope signatures” Cell Reports.
Tálas et al. (2026) “RNA-LNP–mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type I” Science Translational Medicine.
DOI: 10.1126/scitranslmed.aec7274
Read
about Tálas et al. (2026) “RNA-LNP–mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type I” Science Translational Medicine.
Dosey et al. (2026) “Stabilization of the H5 clade 2.3.4.4b hemagglutinin improves vaccine-elicited neutralizing antibody responses in mice” Science Translational Medicine.
DOI: 10.1126/scitranslmed.aea8770
Read
about Dosey et al. (2026) “Stabilization of the H5 clade 2.3.4.4b hemagglutinin improves vaccine-elicited neutralizing antibody responses in mice” Science Translational Medicine.
Oyedele et al. (2026) “A novel SARS-CoV-2 mRNA virus-like particle vaccine is highly potent and well tolerated in adults in a phase 1 randomized clinical trial” Vaccine.
DOI: 10.1016/j.vaccine.2026.128304
Read
about Oyedele et al. (2026) “A novel SARS-CoV-2 mRNA virus-like particle vaccine is highly potent and well tolerated in adults in a phase 1 randomized clinical trial” Vaccine.
Castaño et al. (2025) “Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses” Cell.
DOI: 10.1016/j.cell.2025.11.023
Read
about Castaño et al. (2025) “Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses” Cell.
Laliberte et al. (2025) “Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2” NPJ Vaccines.
DOI: 10.1038/s41541-025-01303-w
Read
about Laliberte et al. (2025) “Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2” NPJ Vaccines.
Yengo et al. (2025) “Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations” Frontiers in Immunology.
DOI: 10.3389/fimmu.2025.1722596
Read
about Yengo et al. (2025) “Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations” Frontiers in Immunology.
Styles et al. (2025) “Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques” Cell Reports Medicine.
DOI: 10.1016/j.xcrm.2025.102369
Read
about Styles et al. (2025) “Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques” Cell Reports Medicine.
Lawtrakulngam et al. (2025) “Enhancing osseointegration with LNP-delivered mRNA–encoded BMP-2: An experimental in vivo study” Clinical Oral Implants Research.
DOI: 10.1111/clr.70057
Read
about Lawtrakulngam et al. (2025) “Enhancing osseointegration with LNP-delivered mRNA–encoded BMP-2: An experimental in vivo study” Clinical Oral Implants Research.
Hendricks et al. (2025) “Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice” Science Translational Medicine.
DOI: 10.1126/scitranslmed.adu2085
Read
about Hendricks et al. (2025) “Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice” Science Translational Medicine.